Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Öberg

Showing results (601-610 of 683) with videos related to

Pageof 69
Sort By:
Oncotarget|January 13, 2016
Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic targetPrasoon Agarwal, Mohammad Alzrigat, Alba Atienza Párraga, et al.
Regulatory Toxicology and Pharmacology : RTP|April 29, 2014
Advancing the 3Rs in regulatory toxicology - Carcinogenicity testing: Scope for harmonisation and advancing the 3Rs in regulated sectors of the European UnionErwin Annys, Richard Billington, Rick Clayton, et al.
Epigenetics|September 24, 2019
Hypermethylation-associated downregulation of microRNA-4456 in hypersexual disorder with putative influence on oxytocin signalling: A DNA methylation analysis of miRNA genesAdrian E Boström, Andreas Chatzittofis, Diana-Maria Ciuculete, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 1, 2017
Early identification of MCI converting to AD: a FDG PET studyMarco Pagani, Flavio Nobili, Silvia Morbelli, et al.
Lancet (London, England)|November 29, 2011
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 studyMarianne E Pavel, John D Hainsworth, Eric Baudin, et al.
Astronomy and Astrophysics|February 20, 2018
Clustering the Orion B giant molecular cloud based on its molecular emissionEmeric Bron, Chloé Daudon, Jérôme Pety, et al.
Psychological Medicine|March 13, 2019
Maternal polycystic ovary syndrome and risk of neuropsychiatric disorders in offspring: prenatal androgen exposure or genetic confounding?Carolyn E Cesta, Anna S Öberg, Abraham Ibrahimson, et al.
Plos One|April 14, 2017
Correction: Altered regulation and expression of genes by BET family of proteins in COPD patientsRajneesh Malhotra, Nisha Kurian, Xiao-Hong Zhou, et al.
Plos One|March 2, 2017
Altered regulation and expression of genes by BET family of proteins in COPD patientsRajneesh Malhotra, Nisha Kurian, Xiao-Hong Zhou, et al.
BMC Research Notes|December 5, 2021
Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern SwedenKarin Holm, Maria N Lundgren, Jens Kjeldsen-Kragh, et al.
Pageof 69

Showing results (601-610 of 683) with videos related to

Sort By:
Pageof 69
Oncotarget|January 13, 2016
Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic targetPrasoon Agarwal, Mohammad Alzrigat, Alba Atienza Párraga, et al.
Regulatory Toxicology and Pharmacology : RTP|April 29, 2014
Advancing the 3Rs in regulatory toxicology - Carcinogenicity testing: Scope for harmonisation and advancing the 3Rs in regulated sectors of the European UnionErwin Annys, Richard Billington, Rick Clayton, et al.
Epigenetics|September 24, 2019
Hypermethylation-associated downregulation of microRNA-4456 in hypersexual disorder with putative influence on oxytocin signalling: A DNA methylation analysis of miRNA genesAdrian E Boström, Andreas Chatzittofis, Diana-Maria Ciuculete, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 1, 2017
Early identification of MCI converting to AD: a FDG PET studyMarco Pagani, Flavio Nobili, Silvia Morbelli, et al.
Lancet (London, England)|November 29, 2011
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 studyMarianne E Pavel, John D Hainsworth, Eric Baudin, et al.
Astronomy and Astrophysics|February 20, 2018
Clustering the Orion B giant molecular cloud based on its molecular emissionEmeric Bron, Chloé Daudon, Jérôme Pety, et al.
Psychological Medicine|March 13, 2019
Maternal polycystic ovary syndrome and risk of neuropsychiatric disorders in offspring: prenatal androgen exposure or genetic confounding?Carolyn E Cesta, Anna S Öberg, Abraham Ibrahimson, et al.
Plos One|April 14, 2017
Correction: Altered regulation and expression of genes by BET family of proteins in COPD patientsRajneesh Malhotra, Nisha Kurian, Xiao-Hong Zhou, et al.
Plos One|March 2, 2017
Altered regulation and expression of genes by BET family of proteins in COPD patientsRajneesh Malhotra, Nisha Kurian, Xiao-Hong Zhou, et al.
BMC Research Notes|December 5, 2021
Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern SwedenKarin Holm, Maria N Lundgren, Jens Kjeldsen-Kragh, et al.
Pageof 69